(Q42251627)

19 October 2017

title

Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? (English)

1 reference

19 October 2017

0 references

2

Frits R Mooi

1 reference

19 October 2017

6

Hester E de Melker

1 reference

19 October 2017

author name string

Nicoline A T van der Maas

1

1 reference

19 October 2017

Sabine C de Greeff

3

1 reference

19 October 2017

Guy A M Berbers

4

1 reference

19 October 2017

Marina A E Conyn-van Spaendonck

5

1 reference

19 October 2017

language of work or name

English

0 references

publication date

6 August 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

31

1 reference

19 October 2017

issue

41

1 reference

19 October 2017

page(s)

4541-4547

1 reference

Morbidity of pertussis in adolescents and adults

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Epidemic pertussis in 2012--the resurgence of a vaccine-preventable disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Reemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Estimation of vaccine effectiveness using the screening method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Pertussis disease burden in the household: how to protect young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Waning protection after fifth dose of acellular pertussis vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Pregnant women in UK are offered whooping cough vaccine to protect newborns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Pertussis cocoon strategy: would it be useful for Latin America and other developing countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Duration of immunity against pertussis after natural infection or vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

SNP-based typing: a useful tool to study Bordetella pertussis populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Population diversity among Bordetella pertussis isolates, United States, 1935-2009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Pertactin-negative variants of Bordetella pertussis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

Improving pertussis vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.07.060

10.1016/J.VACCINE.2013.07.060

7 January 2021

Identifiers

DOI

1 reference

19 October 2017

1 reference